Delcath Systems Overview

  • Founded
  • 1987

Founded
  • Status
  • Public

  • Employees
  • 55

Employees
  • Stock Symbol
  • DCTH

Stock Symbol
  • Share Price
  • $4.80

  • (As of Friday Closing)

Delcath Systems General Information

Description

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Contact Information

Website
www.delcath.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Diagnostic Equipment
Therapeutic Devices
Stock Exchange
NAS
Primary Office
  • 1633 Broadway
  • 22nd Floor, Suite C
  • New York, NY 10019
  • United States
+1 (212) 000-0000

Delcath Systems Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Delcath Systems Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.80 $4.50 $3.49 - $11.95 $41.3M 8.6M 30K -$3.81

Delcath Systems Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 31,562 48,309 96,059 (11,655)
Revenue 3,804 3,555 1,646 1,580
EBITDA (27,819) (24,317) (23,814) (3,884)
Net Income (30,332) (25,649) (24,156) (8,879)
Total Assets 21,066 33,124 34,635 14,212
Total Debt 16,428 16,255 2,945 2,861
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Delcath Systems Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Delcath Systems‘s full profile, request access.

Request a free trial

Delcath Systems Patents

Delcath Systems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200300839-A1 Method of selecting chemotherapeutic agents for an isolated organ or regional therapy Pending 28-Aug-2012 00000000000
US-9541544-B1 Method of selecting chemotherapeutic agents for an isolated organ or regional therapy Active 28-Aug-2012 00000000000 0
EP-3603693-A1 Filter and frame apparatus and method of use Granted 29-Dec-2011 0000000000 0
EP-2797644-A1 Filter and frame apparatus and method of use Granted 29-Dec-2011 0000000000
EP-3360588-A1 Filter and frame apparatus and method of use Granted 29-Dec-2011 A61M1/3626 0
To view Delcath Systems’s complete patent history, request access »

Delcath Systems Executive Team (10)

Name Title Board Seat Contact Info
Gerard Michel Chief Executive Officer & Chief Accounting Officer, Accounting
Jennifer Simpson Ph.D Chief Executive Officer, Board Member & President
John Purpura Chief Operating Officer, Operations
David Hoffman General Counsel & Chief Compliance Officer
Barbra Keck Secretary, Administration
You’re viewing 5 of 10 executive team members. Get the full list »

Delcath Systems Board Members (11)

Name Representing Role Since
000000000 00000000 Self Board Member 000 0000
00000 000000 Delcath Systems Board Member 000 0000
00000000 0000000 00.0 Delcath Systems Chief Executive Officer, Board Member & President 000 0000
0000 000000000 Delcath Systems Board Member 000 0000
00000 00000 00.0 Delcath Systems Chairman & Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »

Delcath Systems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Delcath Systems Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Delcath Systems‘s full profile, request access.

Request a free trial